The future of melanoma detection: Targeted screening, technology and the changing landscape

How will melanoma detection change over the next decade?

In this episode from MIA’s podcast Melanoma Insights for Professionals, our multidisciplinary experts explore how targeted screening, personalised risk assessment, advanced imaging, artificial intelligence and evolving models of care could transform the way melanoma is detected.

The discussion provides insight into how we can identify those most likely to benefit from screening, reduce unnecessary biopsies and surveillance, and make better use of Australia’s limited healthcare workforce and resources.

This podcast is suitable for dermatologists, skin cancer doctors, GPs, nurses, public health researchers and other healthcare professionals.

LEARNING OBJECTIVES

• Identify key risk factors for melanoma and describe how risk stratification can be used to inform personalised prevention, skin checks and surveillance.

• Discuss the potential benefits, harms and limitations of targeted melanoma screening and emerging detection technologies, including imaging and artificial intelligence (AI).

• Discuss the implications of evolving melanoma detection strategies for general practice, including workforce requirements, models of care, triage and referral pathways.

REFERENCES AND RESOURCES

• Yan S, Yu Z, Primiero C, Vico-Alonso C, et al. Amultimodal vision foundation model for clinical dermatology. Nat Med. 2025 Aug;31(8):2691-2702.
• Snoswell CL, Caffery LJ, Whitty JA, et al. Cost-effectiveness of Skin Cancer Referraland Consultation Using Teledermoscopy in Australia. JAMA Dermatol. 2018;154(6):694–700.
• MIA's Melanoma Risk Prediction Calculators
• More information on the Roadmap for a National Targeted Melanoma Screening Program.

ACCREDITATION

This podcast has been accredited for 0.5 EA CPD hours in the RACGP and SkinPro CPD Programs. To obtain a Certificate of Completion and have CPD hours uploaded on your behalf, please listen to this podcast via the Melanoma Education Portal (free registration required).

SPEAKERS

Prof Pascale Guitera
Director of the Sydney Melanoma Diagnostic Centre at Royal Prince Alfred Hospital | Professorial Research Fellow, The University of Sydney | Faculty Member, Melanoma Institute Australia

Prof Rachael Morton

Director of Health Economics and Health Technology Assessment, The Sydney Clinical Trials Centre, The University of Sydney | Faculty Member, Melanoma Institute Australia

Prof Victoria Mar

Director of the Victorian Melanoma Service at The Alfred | Professor of DermatoOncology, School of Public Health and Preventive Medicine, Monash University

Dr Amelia Smit
Senior Research Fellow in Cancer Epidemiology , The Daffodil Centre, The University of Sydney and Cancer Council NSW

Please note that this podcast was accurate at the time of recording (September 2026) but may not reflect the rapidly evolving treatment landscape and approvals in Australia.

MIA’s Education Program is proudly supported through unrestricted educational grants from BMS, MSD and HEINE.